NCT05279677 2022-08-23FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced StageChineseAMSPhase 2 Unknown30 enrolled
NCT04695470 2021-01-07Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer PatientsChineseAMSPhase 2 Unknown70 enrolled